Abstract 1443
Case Summary
Metastases in meningiomas are rare. Here is a case of a 60-year-old gentleman with 1-year history of right parietal swelling, treated as right parietal osteoma. However, symptoms worsen with increasing scalp swelling with headache and vomiting. MRI showed right parietal enplaque meningioma with calvarial involvement. 1st craniotomy, excision of tumor and titanium cranioplasty on January 2014. HPE reported as meningioma, WHO Grade 1. Surveillance MRI done showed stable lesion unlikely residual. Early 2017 he had the same symptom associated with right hemiparesis. MRI suggestive of tumour recurrence at surgical bed extending to left parasagittal parietal with involvement of adjacent left parietal bone, scalp, and superior sagittal sinus. 2nd craniotomy with tumor excision done on March 2017 with HPE reported as grade 1 meningioma. Subsequent MRI showed recurrence at right posterior parietal extra-axial bulk of tumor with mass effect. Proceed with 3rd operation, HPE reported as atypical meningioma, WHO grade II with bone invasion. Another MRI done showed new adjacent left high parietal meningioma. He was monitored and repeated MRI April 2018 tumor become larger. Clinically there are 2 lumps at previous surgical site associated with right upper limb focal seizure. During pre-operative investigation baseline chest x-ray showed large left lower lobe mass. CT Thorax in May 2018 reported confirm large lower lobe mass with another smaller lesion at left upper lobe. Lung biopsy done and consistent with metastatic meningioma. Planned for lobectomy and metastetectomy. However, upon reviewing him chest X-ray showed rapid progression of lung mass with poor performance status. Thus, he was offered best supportive care.
Editorial acknowledgement
Clinical trial identification
Resources from the same session
1310 - Upgrade of Low Grade Ductal Carcinoma in situ (DCIS): multimodality approach in a 10-year single institution study
Presenter: Ajung Chu
Session: Poster display - Cocktail
Resources:
Abstract
489 - Correlation between circulating tumor cells and the aromatase inhibitors therapy in postoperative patients with early breast cancer.
Presenter: Yumei Shi
Session: Poster display - Cocktail
Resources:
Abstract
838 - A Pilot Study of Single Pegfilgrastim Compared with Intermittent Every Other Days of 5 Shot-filgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) Chemotherapy (G-CSF 105 trial: NCT02685111)
Presenter: Jaeho Jeong
Session: Poster display - Cocktail
Resources:
Abstract
1337 - Painful scalp during chemotherapy induced hair loss is associated to permanent alopecia in breast cancer patients
Presenter: Nesrine Mejri
Session: Poster display - Cocktail
Resources:
Abstract
1445 - Breast cancer survival analysis in East Azerbaijan: five years cancer registry data in Iran
Presenter: Shima Pashaei
Session: Poster display - Cocktail
Resources:
Abstract
1457 - Is sarcopenia associated with increased toxicity of neoadjuvant/adjuvant chemotherapy for breast cancer?
Presenter: Ayako Ueno
Session: Poster display - Cocktail
Resources:
Abstract
759 - A Study on possibility of High Sensitivity C - reactive protein (hs-CRP) and Circulating Interluekin-6 (IL-6) as biomarker in Breast Cancer Patients
Presenter: Md Shah Jalalur Rahman Shahi
Session: Poster display - Cocktail
Resources:
Abstract
1447 - Correlation Between Expression of Topoisomerase II Alpha with Ki-67 and Tumor Size in Luminal B-Like Indonesian Breast Cancer Patients
Presenter: Helenia Putri
Session: Poster display - Cocktail
Resources:
Abstract
1175 - Association of Serum Vitamin D Level and Vitamin D Receptor Polymorphism (Apa 1) And Breast Cancer
Presenter: Suzy Gohar
Session: Poster display - Cocktail
Resources:
Abstract
911 - Prognostic Nomograms for Predicting Overall and Cancer-Specific Survival in Breast Cancer Patients Not Achieving Pathological Complete Response After Neoadjuvant Chemotherapy
Presenter: Jianguo Lai
Session: Poster display - Cocktail
Resources:
Abstract